Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prulifloxacin in Acute Gastroenteritis
NCT00392574Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute gastroenteritis comparing Prulifloxacin with Placebo (2 arms). Primary endpoint: Time to last unformed stool. Started Aug 2006; status: completed.
02
Drugs
prulifloxacin
03
Conditions
acute gastroenteritis
Beyond the preview
Go deeper on NCT00392574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392574.